Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05802940 · ClinicalTrials.gov registry record · NA
Low Dose Aspirin Alerts in High-Risk Pregnancies
A NA study of Preeclampsia and Aspirin, sponsored by Geisinger Clinic.
- Active
- Registry status
- NA
- Development phase
- 839
- Enrollment target
- 1
- Study location
NCT05802940: Active NA study of Preeclampsia and Aspirin, sponsored by Geisinger Clinic.
NCT05802940 is a NA study of Preeclampsia and Aspirin that is active but no longer recruiting, run by Geisinger Clinic. The registered enrollment target is 839 participants, below the 1,109-participant average among 48 other Preeclampsia trials with a reported enrollment target (24% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05802940, a NA study of Preeclampsia and Aspirin, is active but no longer recruiting, sponsored by Geisinger Clinic.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 839 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to assess the effect of an electronic health record (EHR) clinical decision support tool, also known as a best practice alert (BPA), on healthcare provider recommendations for low dose aspirin use in a high-risk pregnant patient population. The investigators hypothesize that the implementation of the EHR BPA tool will increase the healthcare provider's recommendation for low dose aspirin compared to current standard care.
Primary Outcome
yes/no
Conditions Studied
Interventions
- BEHAVIORAL Electronic health record best practice alert
Study Locations (1)
Pennsylvania
- Geisinger Medical Center - Danville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 839 participants |
| Start Date | 2023-06-19 |
| Est. Completion | 2026-02-28 |
| Phase | NA |
What the registry record for NCT05802940 still lists
NCT05802940 is an interventional study that assigns participants to a tested intervention. The registered 839 participants enrollment target is mid-sized for trials with a published cap, below the 1,109-participant average among 48 other Preeclampsia trials with a reported enrollment target (24% lower).
The record links to 4 conditions, with Preeclampsia appearing as the primary indexed condition, and to 1 intervention - of which Electronic health record best practice alert is the first listed.
NCT05802940 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05802940 about?
NCT05802940 is a clinical study titled "Low Dose Aspirin Alerts in High-Risk Pregnancies". The goal of this study is to assess the effect of an electronic health record (EHR) clinical decision support tool, also known as a best practice alert (BPA), on healthcare provider recommendations for low dose aspirin use in a high-risk pregnant patient population. The investigators hypothesize tha...
What is the current status of trial NCT05802940?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 839 participants. The study started on 2023-06-19. Estimated completion is 2026-02-28.
What conditions does trial NCT05802940 study?
This clinical trial studies the following conditions: Preeclampsia, Aspirin, Clinical Decision Support Systems, Economics, Behavioral.
What interventions are being tested in trial NCT05802940?
The interventions under investigation include: Electronic health record best practice alert (BEHAVIORAL).
Who is sponsoring clinical trial NCT05802940?
This trial is sponsored by Geisinger Clinic, which has 107 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05802940 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Preeclampsia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05802940's enrollment target sits among peer trials
839 9th of 48 higher than 40 of 48 other Preeclampsia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Preeclampsia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Eliminating Severe Maternal Morbidity With Heart Health Doulas Trial
RECRUITING · NA
-
Optimizing Cardiovascular Preventive Care for Women Following Hypertensive Disorders of Pregnancy
RECRUITING · NA
-
The ACHIEVE Trial: Achieving Longer Gestation in Preeclampsia Via Antihypertensive Therapy.
RECRUITING · NA
-
Preventing Obstetric Complications With Dietary Intervention
RECRUITING · NA
-
Continuous Positive Airway Pressure (CPAP) for Sleep Apnea in Pregnancy
RECRUITING · NA
-
Evaluating the Effectiveness of a Food is Medicine Community Health Worker Program for Pregnant Women
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04831580 · 840 participants · NA
A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer
- NCT04976881 · 840 participants · NA
Promoting Preconception Care and Diabetes Self-Management Among Reproductive-Aged Women With Diabetes
- NCT04985903 · 840 participants · NA
Baby Steps III: Testing a Clinician and Patient Intervention to Promote Smoking Cessation Among Pregnant Women
- NCT05384626 · 840 participants · Phase 1
A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI